Divalent lead cations induce cyclooxygenase-2 gene expression by epidermal growth factor receptor/nuclear factor-kappa B signaling in A431carcinoma cells

Toxicology Letters

Volumn 203, Issue 2, 2011, Pages 147-153

  Chou, Yii Her ^b   Woon, Peng Yeong ^e   Huang, Wan Chen ^d   Shiurba, Robert ^f   Tsai, Yao Ting ^a   Wang, Yu Shiuan ^a   Hsieh, Tusty Jiuan ^a   Chang, Wen Chang ^d,g   Chuang, Hung Yi ^a   Chang, Wei Chiao ^a,b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

^f WASEDA UNIVERSITY   (Japan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cyclooxygenase 2; EGFR; Lead

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; BETA ACTIN; CYCLOOXYGENASE 2; DIVALENT CATION; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEAD; LEAD NITRATE; MESSENGER RNA; SMALL INTERFERING RNA;

ARTICLE; CARCINOMA CELL; CELL LINE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CATIONS, DIVALENT; CELL LINE, TUMOR; CELL NUCLEUS; CELLS, CULTURED; CYCLOOXYGENASE 2; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LEAD; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSFECTION;

ANIMALIA;

EID: 79955476519     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.03.017     Document Type: Article

References (28)

1. Appleby S.B., Ristimaki A., Neilson K., Narko K., Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem. J. 1994, 302(Pt 3):723-727.
2. Carasso R.L., Vardi J., Rabay J.M., Zor U., Streifler M. Measurement of prostaglandin E2 in cerebrospinal fluid in patients suffering from stroke. J. Neurol. Neurosurg. Psychiatry 1977, 40:967-969.
3. Chang W.C., Chang C.C., Wang Y.S., Weng W.T., Yoshioka T., Juo S.H. Involvement of the epidermal growth factor receptor in Pb(2+)-induced activation of cPLA(2)/COX-2 genes and PGE(2) production in vascular smooth muscle cells. Toxicology 2010.
4. Chen B.C., Lin W.W. PKC- and ERK-dependent activation of I kappa B kinase by lipopolysaccharide in macrophages: enhancement by P2Y receptor-mediated CaMK activation. Br. J. Pharmacol. 2001, 134:1055-1065.
5. Chen L.C., Chen B.K., Chang J.M., Chang W.C. Essential role of c-Jun induction and coactivator p300 in epidermal growth factor-induced gene expression of cyclooxygenase-2 in human epidermoid carcinoma A431 cells. Biochim. Biophys. Acta 2004, 1683:38-48.
6. Chen L.C., Chen B.K., Chang W.C. Activating protein 1-mediated cyclooxygenase-2 expression is independent of N-terminal phosphorylation of c-Jun. Mol. Pharmacol. 2005, 67:2057-2069.
7. Cheng Y., Schwartz J., Vokonas P.S., Weiss S.T., Aro A., Hu H. Electrocardiographic conduction disturbances in association with low-level lead exposure (the Normative Aging Study). Am. J. Cardiol. 1998, 82:594-599.
8. Chetty C.S., Vemuri M.C., Campbell K., Suresh C. Lead-induced cell death of human neuroblastoma cells involves GSH deprivation. Cell. Mol. Biol. Lett. 2005, 10:413-423.
9. Cipollone F., Prontera C., Pini B., Marini M., Fazia M., De Cesare D., Iezzi A., Ucchino S., Boccoli G., Saba V., Chiarelli F., Cuccurullo F., Mezzetti A. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 2001, 104:921-927.
10. Colina-Chourio J.A., Godoy-Godoy N., Avila-Hernandez R.M. Role of prostaglandins in hypertension. J. Hum. Hypertens. 2000, 14(Suppl. 1):S16-S19.
11. Eliopoulos A.G., Dumitru C.D., Wang C.C., Cho J., Tsichlis P.N. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 2002, 21:4831-4840.
12. Hla T., Neilson K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:7384-7388.
13. Hyde C.A., Missailidis S. Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumour-angiogenesis. Int. Immunopharmacol. 2009, 9:701-715.
14. Inoue H., Yokoyama C., Hara S., Tone Y., Tanabe T. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J. Biol. Chem. 1995, 270:24965-24971.
15. Jones D.A., Carlton D.P., McIntyre T.M., Zimmerman G.A., Prescott S.M. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 1993, 268:9049-9054.
16. Lustberg M., Silbergeld E. Blood lead levels and mortality. Arch. Intern. Med. 2002, 162:2443-2449.
17. Menke A., Muntner P., Batuman V., Silbergeld E.K., Guallar E. Blood lead below 0.48micromol/L (10microg/dL) and mortality among US adults. Circulation 2006, 114:1388-1394.
18. Navas-Acien A., Selvin E., Sharrett A.R., Calderon-Aranda E., Silbergeld E., Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 2004, 109:3196-3201.
19. Nie M., Pang L., Inoue H., Knox A.J. Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors, and histone h4 acetylation. Mol. Cell. Biol. 2003, 23:9233-9244.
20. Pirkle J.L., Schwartz J., Landis J.R., Harlan W.R. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am. J. Epidemiol. 1985, 121:246-258.
21. Schober S.E., Mirel L.B., Graubard B.I., Brody D.J., Flegal K.M. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ. Health Perspect. 2006, 114:1538-1541.
22. Schwartz J. Lead, blood pressure, and cardiovascular disease in men and women. Environ. Health Perspect. 1991, 91:71-75.
23. Singh B., Berry J.A., Shoher A., Ramakrishnan V., Lucci A. COX-2 overexpression increases motility and invasion of breast cancer cells. Int. J. Oncol. 2005, 26:1393-1399.
24. Steenland K., Boffetta P. Lead and cancer in humans: where are we now?. Am. J. Ind. Med. 2000, 38:295-299.
25. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
26. Xie W., Fletcher B.S., Andersen R.D., Herschman H.R. v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol. Cell. Biol. 1994, 14:6531-6539.
27. Xu Q., Ji Y.S., Schmedtje J.F. Sp1 increases expression of cyclooxygenase-2 in hypoxic vascular endothelium, Implications for the mechanisms of aortic aneurysm and heart failure. J. Biol. Chem. 2000, 275:24583-24589.
28. Zhu Y., Saunders M.A., Yeh H., Deng W.G., Wu K.K. Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins. J. Biol. Chem. 2002, 277:6923-6928.